IMPROVED DOSING REGIMEN OF TEMOZOLOMIDE FOR TREATING CANCER BASED ON THE PATIENT S MGMT LEVEL.

摘要

The use of temozolomide for the manufacture of a medicament for treating cancerin a patient in need of such treating is disclosed comprising administering temozolomideaccording to improved dosing regimen and/or schedules based on the patient'sMGMT level. Additional improved dosing regimen and/or schedules for treatingpatients with temozolomide are also dislosed.